Navamedic to launch Alflorex in Nordic region

6 August 2019 - Deborah Wilkes


Navamedic will launch Alflorex for IBS in Denmark, Iceland and Norway as part of a strategic partnership with PrecisionBiotics, a subsidiary of the Irish probiotic specialist Alimentary Health Group.

Click tags below for more information on topics:

Navamedic Novozymes

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: